Cargando…
An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma
Human glioblastoma (GBM) is the most aggressive malignancy of the CNS, with less than 5% survival. Despite great efforts to find effective therapeutics, current options remain very limited. To develop a targeted cancer therapeutic, we selected RNA aptamers against platelet-derived growth factor rece...
Autores principales: | Yoon, Sorah, Wu, Xiwei, Armstrong, Brian, Habib, Nagy, Rossi, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307106/ https://www.ncbi.nlm.nih.gov/pubmed/30594071 http://dx.doi.org/10.1016/j.omtn.2018.11.012 |
Ejemplares similares
-
Aptamers: Uptake mechanisms and intracellular applications()
por: Yoon, Sorah, et al.
Publicado: (2018) -
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
por: Yoon, Sorah, et al.
Publicado: (2019) -
Targeted Molecular Imaging Using Aptamers in Cancer
por: Yoon, Sorah, et al.
Publicado: (2018) -
Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
por: Yoon, Sorah, et al.
Publicado: (2016) -
Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature
por: Boonstra, Pieter A., et al.
Publicado: (2017)